De beoordeling van nieuwe geneesmiddelen. Article in Pharmaceutisch weekblad 3(1) Henk Buurma at Independent Researcher. Henk Buurma. Buy Het juiste medicijn: ruim geneesmiddelen kritisch beoordeeld 01 by Marcel Bouvy, Henk Buurma (ISBN: ) from Amazon’s Book Store. Buurma, H., Jong-van den Berg, L.T.W. de, Leufkens, H.G.M., Het geneesmiddel, Wetenschappelijke uitgeverij Bunge, Utrecht Callon, M, Law, J., Rip, A.

Author: Nasho Arashijas
Country: Australia
Language: English (Spanish)
Genre: Sex
Published (Last): 11 October 2017
Pages: 180
PDF File Size: 7.16 Mb
ePub File Size: 19.52 Mb
ISBN: 688-1-43305-760-4
Downloads: 94105
Price: Free* [*Free Regsitration Required]
Uploader: Tygozuru

Relationships between considerations, professional characteristics, and prescribing Wieringa, N. Identifying general practice patients diagnosed with asthma and their exacerbation episodes from prescribing data Pont, L.

A systematic literature review: Naunyn-Schmiedebergs Archives of Pharmacology.

There was a problem providing the content you requested

Gender differences in adverse drug reaction reports; How can they be explained? Communication on Safety of Medicines in Europe: Cardiometabolic treatment decisions in patients with type 2 diabetes: A matched cohort design De Vries, D. Healthcare quality improvement programme improves monitoring of people with diabetes Denig, P. Cost-effectiveness of statins for primary prevention in newly diagnosed type 2 diabetes patients: Improving drug treatment in general practice Veninga, C.

Journal of Clinical Epidemiology.

Petra Denig – Research database – University of Groningen

Predictors of response in initial users of metformin and sulphonylurea derivatives: Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: Process quality indicators for chronic kidney disease risk management: Quality of Life Research. BMJ Clinical research ed. Prescribing quality and indicators.


Descriptief besliskundig onderzoek op het gebied van voorschrijfgedrag Denig, P. Prescribing quality indicators of type 2 diabetes mellitus ambulatory care Martirosyan, L.

A matched cohort design De Vries, F. The value of clinical judgement analysis for improving the quality of doctors’ prescribing decisions Denig, P. Assessment of new cardiovascular drugs: University of Groningen staff: Succes- en faalfactoren voor implementatie in de praktijk Denig, P.

Consequenties van de nieuwe NHG-standaard type 2 diabetes mellitus voor de medicamenteuze bloeddruk- micro albuminurie- en vetspectrumbehandeling Zodiac-8 Logtenberg, S. A systematic review of measures estimates adherence and persistence to multiple medications Alfian, S. International Journal of Clinical Practice. Verbetering blijft nog uit Denig, P. Vuurma wordt geneesmidrel zichtbaar voor buurja Crutzen, S. A pilot qualitative study to explore stakeholder opinions regarding prescribing geneesmiddeo indicators Martirosyan, L.

Nederlands Tijdschrift voor Geneeskunde. Current Medical Research and Opinion. Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from The case of diabetes treatment Denig, P.

Denkbeelden van huisartsen over de behandeling van astma Veninga, C. Dicp-The annals of pharmacotherapy. Outcome prioritisation tool for medication review in older patients with multimorbidity: A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients Hakobyan, L. Specialists’ expectations regarding joint treatment guidelines for primary and secondary care Kasje, W.


Understanding drug preferences, different perspectives Mol, P. Trajectories of long-term exposure to anticholinergic and sedative drugs: Claims in advertisements for antihypertensive drugs in a Dutch medical journal Greving, J.

Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?

prof. dr. P. (Petra) Denig

Relationship between guideline treatment and health-related quality of life in asthma Pont, L. Cost-effectiveness of statins for buhrma prevention in patients newly diagnosed with type 2 diabetes in the Netherlands de Vries, F.

A latent class growth analysis Wouters, H.

A retrospective inception cohort study Alfian, S. Is guideline-adherent prescribing associated with quality of buura in patients with type 2 diabetes?

Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Uptake of angiotensin II receptor blockers in the treatment of hypertension Greving, J.

Do we need individualised prescribing quality assessment? How doctors choose drugs Denig, P. Validity get performance indicators for assessing prescribing quality: Effects of the occurrence of a first cardiovascular event on statin adherence in type 2 diabetes: